Inhibition of Angiogenesis and Vascular Leakiness by Angiopoietin-Related Protein 4

Cancer Research

Volumn 63, Issue 20, 2003, Pages 6651-6657

  Ito, Yasuhiro ^a,e   Oike, Yuichi ^a   Yasunaga, Kunio ^c   Hamada, Koichi ^b   Miyata, Keishi ^b   Matsumoto, Shun Ichiro ^c,d   Sugano, Sumio ^f   Tanihara, Hidenobu ^e   Masuho, Yasuhiko ^d   Suda, Toshio ^a  

^a KEIO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c ASTELLAS PHARMA INC   (Japan)

^d Helix Research Institute   (Japan)

^e KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^f UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN RELATED PROTEIN 4; ENDOTHELIAL CELL GROWTH FACTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; BLOOD VESSEL; BLOOD VESSEL PERMEABILITY; CANCER GROWTH; CARCINOGENESIS; CELL PROLIFERATION; CHEMOTAXIS; CONTROLLED STUDY; CORNEA NEOVASCULARIZATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; KERATINOCYTE; NEOVASCULARIZATION (PATHOLOGY); NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REGULATORY MECHANISM; SKIN;

ANGIOGENESIS INHIBITORS; ANIMALS; CAPILLARY PERMEABILITY; CELL DIVISION; CELL MOVEMENT; CELLS, CULTURED; CHEMOTAXIS; CORNEA; ENDOTHELIUM, VASCULAR; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, INBRED BALB C; MICROTUBULES; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PHYSIOLOGIC; RECOMBINANT PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 0142188732     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Risau, W. Mechanisms of angiogenesis. Nature (Lond.), 386: 671-674, 1997.
2. Carmeliet, P. Mechanism of angiogenesis and arteriogenesis. Nat. Med., 6: 389-395, 2000.
3. Hanahan, D. Signaling vascular morphogenesis and maintenance. Science (Wash. DC), 277: 48-50, 1997.
4. Gale, N. W., and Yancopoulos, G. D. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev., 13: 1055-1066, 1999.
5. Kersten, S., Mandard, S., Tan, N. S., Escher, P., Metzger, D., Chambon, P., Gonalez, F. J., Desvergne, B., and Wahli, W. Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene. J. Biol. Chem., 275: 28488-28493, 2000.
6. Yoon, J. C., Chickering, T. W., Rosen, E. D., Dussault, B., Qin, Y., Soukas, A., Friedman, J. M., Holmes, W. E., and Spiegelman, B. M. Peroxisome proliferator-activated receptor γ target gene encoding a novel angiopoietin-related protein associated with adipose differentiation. Mol. Cell. Biol., 20: 5343-5349, 2000.
7. Koishi, R., Ando, Y., Ono, M., Shimamura, M., Yasumo, H., Fujiwara, T., Horikoshi, H., and Furukawa, H. Angptl3 regulates lipid metabolism in mice. Nat. Genet., 30: 151-157, 2002.
8. 3 and induces blood vessel formation in vivo. J. Biol. Chem., 277: 17281-17290, 2002.
9. Dhanabal, M., LaRochelle, W. J., Jeffers, M., Herrmann, J., Rastelli, L., McDonald, W. F., Chillakuru, R. A., Yang, M., Boldog, F. L., Padigaru, M., McQueeney, K. D., Wu, F., Minskoff, S. A., Shimkets, R. A., and Lichenstein, H. S. Angioarrestin: an antiangiogenic protein with tumor-inhibiting properties. Cancer Res., 62: 3834-3841, 2002.
10. Kaneda, A., Kaminishi, M., Yanagihara, K., Sugimura, T., and Ushijima, T. Identification of silencing of nine genes in human gastric cancers. Cancer Res., 62: 6645-6650, 2002.
11. Williams, R. L., Risau, W., Zerwes, H-G., Drexler, H., Aguzzi, A., and Wagner, E. F. Endothelial cells expressing the polyoma middle T oncogene induce hemangiomas by host cell recruitment. Cell, 57: 1053-1063, 1989.
12. Sato, K., Kawasaki, H., Nagayama, H., Serizawa, R., Ikeda, J., Morimoto, C., Yasunaga, K., Yamaji, N., Tadokoro, K., Juji, T., and Takahashi, T. A. CC chemokine receptors, CCR-1 and CCR-3, are potentially involved in antigen-presenting cell function of human peripheral blood monocyte-derived dendritic cells. Blood, 93: 34-42, 1999.
13. Kenyon, B. M., Voesl, E. E., Chen, C. C., Flynn, E., Folkman, J., and D'Amato, R. J. A model of angiogenesis in the mouse cornea. Investig. Ophthalmol. Vis. Sci., 37: 1625-1632, 1996.
14. Meyer, M., Clauss, M., Lepple-Wienhues, A., Waltenberger, J., Augustin, H. G., Ziche, M., Lanz, C., Büttner, M., Rziha, H-J., and Dehio, C. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signaling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases. EMBO J., 18: 363-374, 1999.
15. Kenyon, B. M., Browne, F., and D'Amato, R. J. Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization. Exp. Eye Res., 64: 971-978, 1997.
16. Thurston, G., Suri, C., Smith, K., McClain, J., Sato, T. N., Yancopoulos, G. D., and McDonald, D. M. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science (Wash. DC), 286: 2511-2514, 1999.
17. Kunisada, T., Yamazaki, H., Hirobe, T., Kamei, S., Omoteno, M., Tagaya, H., Hemmi, H., Koshimizu, U., Nakamura, T., and Hayashi, S. I. Keratinocyte expression of transgenic hepatocyte growth factor affects melanocyte development, leading to dermal melanocytosis. Mech. Dev., 94: 67-78, 2000.
18. Hogan, B., Beddington, R., Costantini, F., and Lacy, E. Manipulating the Mouse Embryo: A Laboratory Manual, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1994.
19. Fox, S. B., Leek, R. D., Weekes, M. P., Whitehouse, R. M., Gatter, K. C., and Harris, A. L. Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis. J. Pathol., 177: 275-283, 1995.
20. Davis, S., Aldrich, T. H., Jones, P. F., Acheson, A., Compton, D. L., Jain, V., Ryan, T. E., Bruno, J., Radziejewski, C., Maisonpierre, P. C., and Yancopoulos, G. D. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell, 87: 1161-1169, 1996.
21. Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., Daly, T. J., Davis, S., Sato, T. N., and Yancopoulos, G. D. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science (Wash. DC), 277: 55-60, 1997.
22. Valenzuela, D. M., Griffiths, J. A., Rojas, J., Aldrich, T. H., Jones, P. F., Zhou, H., McClain, J., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., Huang, T., Papadopoulos, N., Maisonpierre, P. C., Davis, S., and Yancopoulos, G. D. Angiopoietins 3 and 4: diverging gene counterparts in mice and humans. Proc. Natl. Acad. Sci. USA, 96: 1904-1909, 1999.
23. Suri, C., McClain, J., Thurston, G., McDonald, D. M., Zhou, H., Oldmixon, E. H., Sato, T. N., and Yancopoulos, G. D. Increased vascularization in mice overexpressing angiopoietin-1. Science (Wash. DC), 282: 468-471, 1998.
24. Elson, D. A., Thurston, G., Huang, L. E., Ginzinger, D. G., McDonald, D. M., Johnson, R. S., and Arbeit, J. M. Induction or hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1α. Genes Dev., 15: 2520-2532, 2001.
25. Machtens, S., Serth, J., Bokemeyer, C., Bathke, W., Minssen, A., Kollmannsberger, C., Hartmanu, J., Knüchel, R., Kondo, M., Jonas, U., and Kuczyk, M. Expression of the p53 and maspin protein in primary prostate cancer: correlation with clinical features. Int. J. Cancer, 95: 337-342, 2001.
26. Kodama, J., Hashimoto, I., Seki, N., Hongo, A., Yoshinouchi, M., Okuda, H., and Kudo, T. Thrombospondin-1 and -2 messenger RNA expression in epithelial ovarian tumor. Anticancer Res., 21: 2983-2987, 2001.
27. Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., and Dvorak, H. F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science (Wash. DC), 219: 983-985, 1983.
28. Kim, I., Moon, S. O., Koh, K. N., Kim, H., Uhm, C. S., Kwak, H. J., Kim, N. G., and Koh, G. Y. Molecular cloning, expression, and characterization of angiopoietin-related protein. Angiopoietin-related protein induces endothelial cell sprouting. J. Biol. Chem., 274: 26523-26528, 1999.
29. Xin, X., Yang, S., Kowalski, J., and Gerritsen, M. E. Peroxisome proliferator-activated receptor γ ligands are potent inhibitors of angiogenesis in vitro and in vivo. J. Biol. Chem., 274: 9116-9121, 1999.
30. Bishol-Bailey, D., and Hla, T. Endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-Δ 12,14-prostaglandin J2. J. Biol. Chem., 274: 17042-17048, 1999.
31. Shu, H., Wong, B., Zhou, G., Li, Y., Berger, J., Woods, J. W., Wright, S. D., and Cai, T. Q. Activation of PPAR α or γ reduces secretion of matrix metalloproteinase 9 but not interleukin 8 from human monocytic THP-1 cells. Biochem. Biophys. Res. Commun., 267: 345-349, 2000.
32. Kersten, S., Desvergne, B., and Wahli, W. Roles of PPARs in health and disease. Nature (Lond.), 405: 421-424, 2000.
33. Panigrahy, D., Singer, S., Shen, L. Q., Butterfield, C. E., Freedman, D. A., Chen, E. J., Moses, M. A., Kilroy, S., Duensing, S., Fletcher, C., Fletcher, J. A., Hlatky, L., Hahnfeldt, P., Folkman, J., and Kaipainen, A. PPARγ ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis. J. Clin. Investig., 110: 923-932, 2002.
34. Kubota, T., Koshizuka, K., Williamson, E. A., Asou, H., Said, J. W., Holden, S., Miyoshi, I., and Koeffler, H. P. Ligand for peroxisome proliferator-activated receptor γ (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vitro. Cancer Res., 58: 3344-3352, 1998.
35. Suh, N., Wang, Y., Williams, C. R., Risingsong, R., Gilmer, T., Willson, T. M., and Sporn, M. B. A new ligand for the peroxisome proliferator-activated receptor-γ (PPARγ), GW7845, inhibits rat mammary carcinogenesis. Cancer Res., 59: 5671-5673, 1999.
36. Le Jan, S., Amy, C., Cazes, A., Monnot, C., Lamande, N., Favier, J., Philippe, J., Sibony, M., Gasc, J. M., Corvol, P., and Germain, S. Angiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinoma. Am. J. Pathol., 162: 1521-1528, 2003.